JP Morgan Chase
DCOY icon

JP Morgan Chase’s Decoy Therapeutics DCOY Stock Holding History

JP Morgan Chase’s Portfolio DCOY Stock Details DCOY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-1
Closed -$1.49K – 7708
2023
Q2 		$1.49K Buy
+1
New +$2.29K ﹤0.01% 6389
2022
Q2 		– Hold
0
– -$1K – 6850
2022
Q1 		– Hold
0
– – – 6498
2020
Q1 		– Hold
0
– – – 5684
2019
Q4 		– Hold
0
– – – 5865
2019
Q3 		– Hold
0
– – – 5935
2019
Q2 		– Hold
0
– – – 5992
2019
Q1 		– Hold
0
– – – 6016
2018
Q4 		– Hold
0
– – – 5927
2018
Q3 		– Hold
0
– – – 5806
2018
Q2 		– Hold
0
– – – 5679
2018
Q1 		– Hold
0
– – – 4390
2017
Q4 		– Hold
0
– – – 5392
2017
Q3 		– Hold
0
– – – 4912
2017
Q2 		– Hold
0
– – – 4889
2017
Q1 		– Hold
0
– – – 4052
2016
Q4 		– Hold
0
– – – 4024
2016
Q3 		– Hold
0
– – – 3314
2016
Q2 		– Hold
0
– – – 3400
2016
Q1 		– Hold
0
– – – 2470
2015
Q4 		– Hold
0
– – – 2573
2015
Q3 		– Hold
0
– – – 2847
2015
Q2 		– Hold
0
– – – 2843
2015
Q1 		– Hold
0
– – – 2689

Other funds holding DCOY

AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
HKAM
Horizon Kinetics Asset Management New York $8.82B AUM 23.05% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $85.1B AUM 27.35% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

JP Morgan Chase's DCOY Position: Q3 2023 in Review

JP Morgan Chase sold out of Decoy Therapeutics (DCOY) in Q3 2023, closing a stake of 1 share — an estimated $1.49K sold.

JP Morgan Chase first reported a position in DCOY in Q2 2023 and held it in 1 quarter. The position peaked at $1.49K in Q2 2023. 8 funds tracked by Wall St. Rank hold DCOY as of Q3 2023.

  • JP Morgan Chase reported no remaining Decoy Therapeutics position as of Q3 2023 after selling out during the quarter.
  • JP Morgan Chase sold 1 Decoy Therapeutics share in Q3 2023, an estimated $1.49K.
  • JP Morgan Chase first reported a position in Decoy Therapeutics in Q2 2023 and held it in 1 quarter.
  • JP Morgan Chase's Decoy Therapeutics position peaked at $1.49K in Q2 2023.
  • 8 funds tracked by Wall St. Rank held Decoy Therapeutics as of Q3 2023.

Based on JP Morgan Chase's 13F filing for Q3 2023, filed 14 Nov 2023.